Clinical trial
rhTSH, Thyroid Size, and Radioiodine Therapy in Benign Goiter
NCT00145366 · Odense University Hospital, Other · Completed
Key facts
| NCT number | NCT00145366 |
|---|---|
| Title | rhTSH, Thyroid Size, and Radioiodine Therapy in Benign Goiter |
| Official title | Pretreatment With Recombinant Human Thyrotropin (rhTSH) for the Effect on Thyroid Size and Function, and for the Effect of Radioiodine Treatment in Patients With Nodular Goiter. Prospective, Randomized Double-blinded Trials. |
| Lead sponsor | Odense University Hospital, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Benign Nontoxic and Toxic Goiter, Graves' Disease |
| Intervention type | Drug |
| Interventions | Recombinant human thyrotropin (Thyrogen) |
| Enrollment | 110 |
| Start date | Apr 1, 2002 |
| Completion | Jul 1, 2005 |
| First posted | Sep 5, 2005 |
| Last update posted | Dec 28, 2010 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: